Literature DB >> 17624590

No evidence of human papillomavirus DNA sequences in invasive breast carcinoma.

Patricia de Cremoux1, Martine Thioux, Ingrid Lebigot, Brigitte Sigal-Zafrani, Rémy Salmon, Xavier Sastre-Garau.   

Abstract

Breast cancer is one of the most frequently diagnosed cancers in women in France, but its aetiology remains unknown. Viruses including Epstein-Barr virus (EBV), a human equivalent of murine mammary tumour virus (MMTV) and human papillomavirus (HPV) have been detected in benign breast tissues and breast tumours and are considered to be involved in the aetiology of breast cancer. The aim of this study was to determine the prevalence of high-risk oncogenic HPVs in breast carcinoma from French patients. Fifty unselected DNA samples extracted from invasive breast carcinoma tissues were analysed. Polymerase chain reaction (PCR) was performed to amplify both consensus GP5+/GP6+HPV sequences and specific sequences for HPV types 16, 18, 33, 45 and 6-11. No HPV-DNA sequences were detected in our series of 50 samples. These data argue against the role of oncogenic HPV in the pathogenesis of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624590     DOI: 10.1007/s10549-007-9626-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  34 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Absence of human papillomavirus in patients with breast cancer in north-west China.

Authors:  Peng Chang; Ting Wang; Qing Yao; Yonggang Lv; Juliang Zhang; Wen Guo; Ling Wang; Jianghao Chen
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

3.  Assessment of the Association between Human Papillomavirus Infection and Breast Carcinoma.

Authors:  Ali Eslamifar; Amitis Ramezani; Kayhan Azadmanesh; Farahnaz Bidari-Zerehpoosh; Mohammad Banifazl; Arezoo Aghakhani
Journal:  Iran J Pathol       Date:  2015

4.  Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer.

Authors:  Ala-Eddin Al Moustafa; Noor Al-Antary; Tahar Aboulkassim; Nizar Akil; Gerald Batist; Amber Yasmeen
Journal:  Hum Vaccin Immunother       Date:  2016-04-15       Impact factor: 3.452

5.  Frequency of Human Papillomavirus Genotypes 6, 11, 16, 18 And 31 in Paraffin-Embedded Tissue Samples of Invasive Breast Carcinoma, North- East of Iran.

Authors:  Masoumeh Salehpour; Naser Tayyebi Meibodi; Roghayeh Teimourpour; Adel Ghorani-Azam; Samaneh Sepahi; Sina Rostami; Zahra Meshkat
Journal:  Iran J Pathol       Date:  2015

Review 6.  The role of human papillomavirus infection in breast cancer.

Authors:  Ting Wang; Peng Chang; Ling Wang; Qing Yao; Wen Guo; Jianghao Chen; Tristan Yan; Christopher Cao
Journal:  Med Oncol       Date:  2011-02-13       Impact factor: 3.064

7.  Potential use of vaccines in the primary prevention of breast cancer in high-risk patients.

Authors:  Matteo Lazzeroni; Davide Serrano
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

8.  Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis.

Authors:  Ni Li; Xiaofeng Bi; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  Breast Cancer Res Treat       Date:  2010-08-26       Impact factor: 4.872

9.  Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan.

Authors:  Naureen Ehsan Ilahi; Sobia Anwar; Mamoona Noreen; Shoaib Naiyar Hashmi; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-09       Impact factor: 4.553

10.  The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.

Authors:  Ishita Gupta; Ayesha Jabeen; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A Sultan; Ala-Eddin Al Moustafa; Hamda Al-Thawadi
Journal:  Hum Vaccin Immunother       Date:  2020-10-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.